STE - Company ID 0001757898
The table below shows STERIS plc's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $1.34B | $1.15B | $973.27M | $756.95M | $684.81M | $689.64M |
| Capital expenditure | $369.00M | $370.09M | $360.33M | $361.97M | $287.56M | $239.26M |
| Investing cash flow | -$512.50M | $388.77M | -$887.36M | -$383.33M | -$666.56M | -$1.15B |
| Dividends paid | $241.80M | $219.88M | $200.57M | $183.50M |
STERIS plc reported operating cash flow of $1.34B for fiscal year 2026. That is up 16.8% from $1.15B in fiscal 2025. Over the 10 fiscal years shown, operating cash flow grew from $424.09M (FY 2017) to $1.34B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $163.17M |
| $133.84M |
| Stock buybacks | $235.50M | $211.32M | $11.77M | $308.56M | $55.78M | $14.65M |
| Financing cash flow | -$568.20M | -$1.57B | -$85.19M | -$498.72M | $115.83M | $345.62M |